 Advances in cell biology, molecular biology and
tissue engineering have shown that viable (living) cells can be
successfully used as therapeutic agents for the treatment of
disease. This knowledge led to a first generation of cell therapies
which have overcome unique technological and regulatory hurdles to
enter the market. In more recent years, cell-based products have
been designed for specific indications, with cost, ease of use and
manufacture taken into consideration, resulting in a second
generation of commercial cell therapies.
Core Technology and Science Background
Intercytex is a pioneer in whole cell bioprocessing,
specifically isolation, culture, expansion, manufacture and
delivery. This enables the cells to be grown in conditions that
maintain their functionality, allowing them to be successfully used
as therapeutic agents.
Intercytex’ management team possesses over 40 years of
experience in commercialising cell therapies.
|
Contact Us
